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Results: 
 
In figure 1 the reconstructed and literature σ values of 
muscle, bladder and cervical tumor tissue are presented. 
Results show σ values of muscle tissue which are 15-30% 
elevated compared to literature values. Moreover, the 
reconstructed σ values of the bladder were up to 10 times 
higher than values currently used in HTP. Furthermore, for 
75% of the squamous cell carcinomas the σ values were 5-12% 
higher than the σ of muscle tissue. The reconstructed σ of 
the adenocarcinoma was 22% higher compared to muscle 
tissue. 
Conclusions: This study demonstrated the feasibility to 
quantitatively measure the σ of healthy tissue and tumors in 
vivo. The measured conductivities were higher than those 
reported in literature, which could probably be explained by 
the higher blood and water content during living conditions. 
A decrease of σ after death has been reported in literature in 
studies with (human) liver, (animal) brain and (animal) 
muscle tissue. The present study showed that the commonly 
unknown tumor σ is 5-12% higher compared to the in vivo σ of 
muscle. The reconstructed bladder σ was much higher than 
the value currently used in HTP. This can be explained by the 
fact that the σ value reported in the literature corresponds 
to the bladder tissue, not accounting for the highly 
conductive urine. Future studies will determine to which 
extent the reliability of HTP improves when using these 
patient-specific σ values.  
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Purpose/Objective: To evaluate the feasibility of prostate 
cancer EBRT response assessment with [11C]Acetate PET and 
multiparametric magnetic resonance imaging (mpMRI) in the 
absence of a hybrid MR-PET scanner. The study aimed at 
finding the correlation of quantitative parameters changes 
derived from different imaging modalities during the course 
of treatment. 
Materials and Methods: Four cases with biopsy-confirmed 
prostate cancer were included in this IRB approved study. 
Patients received a prescribed dose of 78Gy to the prostate 
and 50.4Gy to elective pelvic nodes. PET-CT and mpMRI scans 
were performed at 4 time points: before RT, after 2 and 4 
weeks of treatment (at ~20 and 40 Gy) and at 3 months after 
RT. For the PET exam 740MBq of [11C]Acetate were injected 
and patients were imaged 20 minutes later. 3T mpMRI scan 
consisted of the following sequences: T2-weighted turbo spin 
echo, diffusion-weighted single-shot echo-planar imaging 
(DWI), 3D Chemical Shift Imaging spectroscopy (CSI) and 
dynamic contrast enhanced (DCE) T1-weighted gradient echo 
with 70 repetitions. ADC, Ktrans, iAUC and Cho+Cr/Ci-ratio 
maps were generated using the Syngo® (Siemens, Germany). 
All images were registered and analzyed in the Mirada RTx 
(Mirada Medical Ltd, UK) using automatic and manual rigid 
registration with respect to three reference gold markers. 
Series of structures (defined on datasets from all consecutive 
time points) consisted of: focal lesion visible on particular 
modality (T2w; ADC-, Ktrans-, iAUC-maps and PET), reference 
PET structure (Gluteus maximus m.) to calculate TBR and the 
dominant intraprostatic lesion (DIL) based on all imaging 
modalities. DIL defined at the baseline was also copied to 
remaining time points (DILB2-4) to assess temporal stability of 
the DIL. Variations in quantitative parameters were extracted 
from the respective imaging series. Statistical analyses were 
performed on collected data. 
Results: Manually delineated DIL mean volume at the 
baseline was 3.1±1.6cc and decreased to 0.25±0.25cc at 
follow up (with 23.0±3.8% and 44.3±28.5% decrease after 2 
and 4 weeks, respectively). Means of quantitative parameters 
in the DIL volumes between baseline and follow up changed 
as follows: ADC increased by 27.1±7.4%, Ktrans decreased by 
41.5±11.4% and iAUC by 34.8±12.2%. Intensity on T2w images 
decreased by 5.2±7.9% and TBR dropped by 25.1±6.5%. The 
behavior of these parameters during treatment differed 
between cases. For example for one patient the lesion was 
not visible on T2w images already after 20Gy, whereas for 
another one it could be recognized even in follow up after 
78Gy. 
Conclusions: Prostate cancer RT assessment is feasible with 
combined [11C]Acetate PET and mpMRI performed on separate 
scanners. Special care has to be devoted to the process of 
image registration. Data derived from different modalities 
complement each other but their correlations need further 
investigations. There is clear inter-patient response variation 
but more patients and long term follow up is needed. The 
impact of temporal DIL variations on boost strategies needs 
further investigation.  
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Purpose/Objective: Neoadjuvant chemoradiotherapy (nCRT) 
is often used for the treatment of resectable esophageal 
cancer. In 29% of the patients complete pathologic response 
(pCr) has been found. When accurate prediction of treatment 
response is available, surgery may potentially be omitted in 
case of pCr. Changes in tumor microvasculature are reflected 
in dynamic contrast enhanced (DCE) MRI, which is therefore 
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increasingly used for response monitoring and prediction. In 
this study the diagnostic potential of DCE-MRI for treatment 
response assessment in esophageal cancer is investigated. 
Materials and Methods: In 12 patients receiving nCRT, DCE-
MRI studies were performed before treatment (pre), after 8-
13 fractions (per) and 5-7 weeks after completion of nCRT, 
prior to surgery (post). After resection pathologic assessment 
of the tumor regression grade (TRG) was performed following 
the Mandard score. For analysis a distinction was made 
between a group of good responders (GR), defined as pCr 
(TRG 1) or near-pCr (TRG 2), and poor responders (noGR) 
with TRG ≥ 3. The primary tumor was delineated on the T2W 
images before, during and after nCRT. This delineated 
volume was contracted with an isotropic margin of 2 mm to 
account for residual motion and partial volume effects. 
Within this contracted volume mean, median and 75th 
percentile (P75) of the AUC of the contrast agent 
concentration was calculated. Here, the AUC was defined as 
the integral over the concentration curve (60 seconds, 
starting at inflow of contrast agent). 
Results: In 4 patients (33%) pCR was found and a total of 5 
patients (42%) showed a good response. Initial P75 AUC values 
were the same across GR and noGR. Relative changes in 
mean, median and P75 AUC between pre and per treatment 
were all found to be significant across the two groups, while 
the same parameters comparing pre and post treatment were 
not significant. All noGR showed an increase in AUC 
comparing relative changes between pre and per treatment 
(fig. A), while 80% of GR remained similar or decreased. The 
ΔP75 pre-per was found to be most predictive (-6%±29% for 
GR [mean ± SD] vs. 76%±58% for noGR, p=0.005) (fig B). With 
a cut-off value of 17.4% an area under the ROC curve of 0.97, 
sensitivity of 80%, specificity of 100%, positive predictive 
value (PPV) of 100% and a negative predictive value (NPV) of 
88% is found.  
 
 
Conclusions: Semi-quantitative parameters from DCE-MRI 
studies of before and during treatment were used for 
treatment response prediction of esophageal cancer. The 
decrease in AUC found for some GR, might indicate a 
renormalization in vasculature. The treatment-induced 
change in P75 AUC after 8-13 fractions of nCRT compared to 
initial values reached high PPV and sensitivity. Although this 
is a limited number of patients, the use of P75 AUC for 
treatment response assessment, seems promising. In the 
future we will continue to include more patients to verify 
whether DCE-MRI can be used as an accurate treatment 
response assessment for esophageal cancer.  
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Purpose/Objective: Tumor delineation is one of the weakest 
links in the radiotherapy treatment chain. In order to 
improve treatment, more insight into the errors made by 
delineation is needed. In this study, gross tumor volume 
(GTV) delineations on CT, MRI and the automatic 
segmentation on FDG-PET of laryngeal and hypopharyngeal 
squamous cell carcinoma are validated on histopathology. 
Materials and Methods: Twenty-one patients were included 
with a laryngeal or hypopharyngeal tumor (T3/T4). Before 
total laryngectomy/partial pharyngectomy, CT, MRI 
(T1weighted and T2weighted) and FDG-PET images were 
made in radiotherapy positioning mask. The GTV was 
delineated in consensus by 3 experienced observers on CT 
and MRI. FDG-PET was delineated semi-automatically using a 
Gaussian mixed model based threshold. Tumor has been 
delineated by a pathologist on whole-mount hematoxylin and 
eosin stained histopathological sections (intersections of 
approximately 3 mm) and afterwards digitized and 
reconstructed to a 3 dimensional specimen. This 3D specimen 
was then registered to the imaging prior to laryngectomy. 
The GTVs, as delineated on the imaging, were compared with 
the histopathological based tumor delineation in three 
dimensions (figure 1). 
 
 
Results: The margin around the GTV needed to ensure 95% of 
tumor surface coverage was 3 mm (SD 2), 4 mm (SD 2) and 4 
mm (SD 2) for CT, MRI and FDG-PET, respectively. In the 
semi-automatic delineation of FDG-PET, for one case a 
margin of 9 mm was needed, probably due to large necrotic 
parts in the tumor. 
The part of the tumor included in the GTV (sensitivity) 
amounted to 86% (SD 9), 80% (SD 11) and 79% (SD 11) for CT, 
MRI and FDG-PET, respectively.  
The overestimation of the tumor volume, the positive 
predictive value (PPV), on CT, MRI and FDG-PET was found to 
be 53% (SD 14), 59% (SD 13) and 66% (SD 15), respectively. 
Conclusions: The tumor extensions outside the delineated 
GTVs are similar for all modalities, based on the margins 
needed to cover 95% of the tumor surface. FDG-PET has the 
highest PPV; therefore semi-automatic delineation of FDG-
PET can be used as an initial delineation of the GTV. This 
delineation must be reviewed by a physician and, if 
